Matches in Wikidata for { <http://www.wikidata.org/entity/Q56381093> ?p ?o ?g. }
Showing items 1 to 35 of
35
with 100 items per page.
- Q56381093 description "article scientifique publié en 2018" @default.
- Q56381093 description "im Mai 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q56381093 description "wetenschappelijk artikel" @default.
- Q56381093 description "наукова стаття, опублікована в травні 2018" @default.
- Q56381093 name "The impact of toceranib, piroxicam and thalidomide with or without hypofractionated radiation therapy on clinical outcome in dogs with inflammatory mammary carcinoma" @default.
- Q56381093 name "The impact of toceranib, piroxicam and thalidomide with or without hypofractionated radiation therapy on clinical outcome in dogs with inflammatory mammary carcinoma" @default.
- Q56381093 type Item @default.
- Q56381093 label "The impact of toceranib, piroxicam and thalidomide with or without hypofractionated radiation therapy on clinical outcome in dogs with inflammatory mammary carcinoma" @default.
- Q56381093 label "The impact of toceranib, piroxicam and thalidomide with or without hypofractionated radiation therapy on clinical outcome in dogs with inflammatory mammary carcinoma" @default.
- Q56381093 prefLabel "The impact of toceranib, piroxicam and thalidomide with or without hypofractionated radiation therapy on clinical outcome in dogs with inflammatory mammary carcinoma" @default.
- Q56381093 prefLabel "The impact of toceranib, piroxicam and thalidomide with or without hypofractionated radiation therapy on clinical outcome in dogs with inflammatory mammary carcinoma" @default.
- Q56381093 P1433 Q56381093-21CB814E-4F71-451A-BF86-07920F81B11A @default.
- Q56381093 P1476 Q56381093-5B6DB2F6-5241-45C2-8B15-6289AA949568 @default.
- Q56381093 P2093 Q56381093-BBBC290B-4351-45C2-8504-6510F090E65C @default.
- Q56381093 P2093 Q56381093-CBCE7A2E-3DCE-4D4D-9249-456E7404C748 @default.
- Q56381093 P2093 Q56381093-DC2904BC-B876-4438-8196-CB48F17C4F06 @default.
- Q56381093 P31 Q56381093-54145D43-AC2A-48B9-B687-AFC31985D100 @default.
- Q56381093 P356 Q56381093-FCF7A360-A48B-4774-8F63-066D72824BE2 @default.
- Q56381093 P407 Q56381093-CE462AA0-3682-4247-A1BB-A3B83BD4DE64 @default.
- Q56381093 P50 Q56381093-0CB565C3-8185-49F3-9E09-48B889EF02CA @default.
- Q56381093 P577 Q56381093-A86E2A71-40F6-40C1-B336-8762BCF0421F @default.
- Q56381093 P698 Q56381093-DD4944A3-FE21-485B-AA09-801D18AD6FFA @default.
- Q56381093 P356 VCO.12407 @default.
- Q56381093 P698 29806156 @default.
- Q56381093 P1433 Q15759976 @default.
- Q56381093 P1476 "The impact of toceranib, piroxicam and thalidomide with or without hypofractionated radiation therapy on clinical outcome in dogs with inflammatory mammary carcinoma" @default.
- Q56381093 P2093 "F Rossi" @default.
- Q56381093 P2093 "M Vascellari" @default.
- Q56381093 P2093 "S Sabattini" @default.
- Q56381093 P31 Q13442814 @default.
- Q56381093 P356 "10.1111/VCO.12407" @default.
- Q56381093 P407 Q1860 @default.
- Q56381093 P50 Q57015396 @default.
- Q56381093 P577 "2018-05-27T00:00:00Z" @default.
- Q56381093 P698 "29806156" @default.